Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

AIM OF THE STUDY: Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The aim of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Juuti, Anne, Nordling, Stig, Fermér, Christian, Nilsson, Olle, Seppänen, Hanna, Haglund, Caj
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459962/
https://ncbi.nlm.nih.gov/pubmed/26053486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0129012
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы